Sign in

CIK 0001526119 · Non-accelerated filer<br>Smaller reporting company

Verastem, Inc.

Sign in to watch
Ticker
VSTM
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
MA
Entity type
operating
EIN
273269467
Phone
(781) 292-4200
Business address
117 KENDRICK STREET, SUITE 500, NEEDHAM, MA, 02494
  1. 4 Grant or award President and CEO acquired 213,785 shares (grant or award)
  2. 4 Planned sale President and CEO sold 10,321 shares at $7.16 ($73,898)
  3. 4 Planned sale Chief Financial Officer sold 5,039 shares at $7.16 ($36,079)
  4. 4 Derivatives Options or other derivatives
  5. 4 Planned sale Chief Financial Officer sold 80 shares at $7.86 ($629)
  6. 4 Planned sale Director sold 592 shares at $9.14 ($5,411)
  7. 4 Planned sale President and CEO sold 393 shares at $9.14 ($3,592)
  8. 4 Planned sale Director sold 283 shares at $9.14 ($2,587)
  9. 4 Planned sale President and CEO sold 4,000 shares at an average $10.04 ($40,140)
  10. 4 Planned sale President and CEO sold 6,000 shares at an average $10.45 ($62,720)
  11. 4 Planned sale President and CEO sold 6,000 shares at an average $10.11 ($60,640)
  12. 4 Planned sale President and CEO sold 6,000 shares at an average $10.50 ($63,000)
  13. 4 Planned sale Director sold 6,250 shares at $10.00 ($62,500)
  14. 4 Planned sale Director sold 8,550 shares at $10.00 ($85,500)
  15. 4 Planned sale President and CEO sold 6,000 shares at $10.00 ($60,000)
  16. 4 Planned sale President and CEO sold 3,299 shares at an average $9.74 ($32,146)
  17. 4 Planned sale Director sold 8,333 shares at $9.06 ($75,497)
  18. 4 Planned sale Chief Financial Officer sold 82 shares at an average $9.13 ($748)
  19. 4 Planned sale Director sold 587 shares at $9.99 ($5,864)
  20. 4 Planned sale Director sold 281 shares at $9.99 ($2,807)

Page 2 of 27 · 526 filings